Blog
RSS FeedPosted by Michael Wonder on 20 Apr 2021
Pfizer and BioNTech to supply the European Union with 100 million additional doses of Comirnaty
19 April 2021 - European Union exercises option under previous agreement to order 100 million additional doses of Comirnaty, bringing total ...
Posted by Michael Wonder on 15 Apr 2021
EU drug regulator to issue view on J&J vaccine next week
15 April 2021 - Europe's drug regulator said on Wednesday it planned to issue a recommendation on Johnson & Johnson's ...
Posted by Michael Wonder on 14 Apr 2021
Europe bets heavily on Pfizer in vaccine strategy overhaul
15 April 2021 - Europe has hinted it will not renew contracts for coronavirus vaccines produced by pharmaceutical giants AstraZeneca ...
Posted by Michael Wonder on 14 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
14 April 2021 - EMA continues to monitor very rare blood clots with low blood platelets that occurred after vaccination ...
Posted by Michael Wonder on 14 Apr 2021
COVID-19 vaccine Janssen: assessment of very rare cases of unusual blood clots with low platelets continues
14 April 2021 - As announced last week, EMA’s safety committee (PRAC) is reviewing very rare cases of unusual blood clots ...
Posted by Michael Wonder on 10 Apr 2021
Johnson & Johnson COVID-19 vaccine under review by EMA over blood clots
10 April 2021 - Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States ...
Posted by Michael Wonder on 08 Apr 2021
AstraZeneca worldwide: who’s using the jab, and who’s not
9 April 2021 - A growing list of countries are either restricting or suspending the use of AstraZeneca vaccine amid it’s ...
Posted by Michael Wonder on 08 Apr 2021
With millions vaccinated, rare side-effects of jabs are emerging
7 April 2021 - Sorting signal from noise. ...
Posted by Michael Wonder on 07 Apr 2021
AstraZeneca’s COVID-19 vaccine: EMA finds possible link to very rare cases of unusual blood clots with low blood platelets
7 April 2021 - EMA confirms overall benefit-risk remains positive. ...
Posted by Michael Wonder on 31 Mar 2021
AstraZeneca COVID-19 vaccine: review of very rare cases of unusual blood clots continues
31 March 2021 - EMA’s safety committee (PRAC) is meeting today in the context of its ongoing review of very ...
Posted by Michael Wonder on 30 Mar 2021
Germany to restrict AstraZeneca use in under-60s over clots
30 March 2021 - German health officials have agreed to restrict the use of AstraZeneca’s coronavirus vaccine in people under 60, ...
Posted by Michael Wonder on 26 Mar 2021
Increase in vaccine manufacturing capacity and supply for COVID-19 vaccines from AstraZeneca, BioNTech/Pfizer and Moderna
26 March 2021 - EMA’s CHMP has adopted several important recommendations that will increase manufacturing capacity and supply of COVID-19 vaccines ...
Posted by Michael Wonder on 26 Mar 2021
Europe slams the brakes on vaccine exports until its needs are met
26 March 2021 - Europe has stepped back from its threat to seize AstraZeneca factories or enact a full vaccine ...
Posted by Michael Wonder on 26 Mar 2021
Takeda begins regulatory submissions for dengue vaccine candidate in EU and Dengue-endemic countries
26 March 2021 - EMA to conduct first-ever parallel assessment of a medicinal product, Takeda’s dengue vaccine candidate (TAK-003), for use ...
Posted by Michael Wonder on 26 Mar 2021
Attacks on AstraZeneca cast doubt over its vaccine pricing, says top scientist
26 March 2021 - The EU’s attacks on AstraZeneca call into question the company’s decision not to profit from its ...